These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22952980)

  • 1. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.
    Cornelissen LA; de Leeuw OS; Tacken MG; Klos HC; de Vries RP; de Boer-Luijtze EA; van Zoelen-Bos DJ; Rigter A; Rottier PJ; Moormann RJ; de Haan CA
    PLoS One; 2012; 7(8):e44447. PubMed ID: 22952980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
    Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
    J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1.
    Cornelissen LA; de Vries RP; de Boer-Luijtze EA; Rigter A; Rottier PJ; de Haan CA
    PLoS One; 2010 May; 5(5):e10645. PubMed ID: 20498717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector.
    Murr M; Grund C; Breithaupt A; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2020 Dec; 64(4):427-436. PubMed ID: 33347549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.
    Murr M; Karger A; Steglich C; Mettenleiter TC; Römer-Oberdörfer A
    J Gen Virol; 2020 May; 101(5):473-483. PubMed ID: 32209169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.
    Nayak B; Rout SN; Kumar S; Khalil MS; Fouda MM; Ahmed LE; Earhart KC; Perez DR; Collins PL; Samal SK
    PLoS One; 2009 Aug; 4(8):e6509. PubMed ID: 19654873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens.
    Kim SH; Paldurai A; Xiao S; Collins PL; Samal SK
    Vaccine; 2014 Jul; 32(35):4428-4435. PubMed ID: 24968158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
    Kim DH; Lee SH; Kim J; Lee J; Jeong JH; Kim JY; Song SU; Lee H; Cho AY; Hyeon JY; Youk S; Song CS
    Vaccine; 2024 Jul; 42(18):3756-3767. PubMed ID: 38724417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of avian influenza virus H5 and N1 by recombinant Newcastle disease virus and the impact on immune response in chickens.
    Ramp K; Veits J; Deckers D; Rudolf M; Grund C; Mettenleiter TC; Römer-Oberdörfer A
    Avian Dis; 2011 Sep; 55(3):413-21. PubMed ID: 22017039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
    Li H; Sun H; Tao M; Han Q; Yu H; Li J; Lu X; Tong Q; Pu J; Sun Y; Liu L; Liu J; Sun H
    J Virol; 2024 Mar; 98(3):e0112923. PubMed ID: 38305155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.
    Xu L; Qin Z; Qiao L; Wen J; Shao H; Wen G; Pan Z
    Vaccine; 2020 Feb; 38(7):1690-1699. PubMed ID: 31937412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.
    Kim SH; Samal SK
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30917500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.